DNAprint Genomics (DNAG)

[worktoplay]

frog...Pardon me for jumping in here, but it is my understanding that Phase I Clinical Trials involve relatively few patients (I have seen numbers ranging from 20-100).

Cost estimates I have seen range from $5,000 to $10,000 per patient.

Given these assumptions, wouldn't you agree it may well be within DNAG's ability to complete the Phase I, and perhaps the Phase II work using their existing funding mechanisms?

And if the $600,000 they just committed covers the cost of the required pre-clinical work, I don't see a tremendous financial burden until they would reach the Phase III trial stage.

JMHO

Later,
W2P